Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus

Second Department of Internal Medicine, University of Tokyo, Japan. yokochan-cky@umin-tokyo.ac.jp

OBJECTIVES: We analyzed myocardial flow reserve (MFR) in patients with non-insulin-dependent (type II) diabetes mellitus (NIDDM) without symptoms and signs of ischemia. BACKGROUND: Diminished MFR in diabetes has been suggested. However, it remains controversial whether MFR is related to glycemic control, mode of therapy or gender in NIDDM. METHODS: Myocardial blood flow (MBF) was measured at baseline and during dipyridamole loading in 25 asymptomatic, normotensive, normocholesterolemic patients with NIDDM and 12 age-matched control subjects by means of positron emission tomography and nitrogen-13 ammonia, after which MFR was calculated. RESULTS: Baseline MBF in patients with NIDDM ([mean +/- SD] 74.0 +/- 24.0 ml/min per 100 g body weight) was comparable to that in control subjects (73.0 +/- 17.0 ml/min per 100 g). However, MBF during dipyridamole loading was significantly lower in patients with NIDDM (184 +/- 99.0 ml/min per 100 g, p < 0.01) than in control subjects (262 +/- 120 ml/min per 100 g), as was MFR (NIDDM: 2.77 +/- 0.85; control subjects: 3.8 +/- 1.0, p < 0.01). A significantly decreased MFR was seen in men (2.35 +/- 0.84) compared with women with NIDDM (3.18 +/- 0.79, p < 0.05); however, no significant differences were found in terms of age, hemoglobin a1c and baseline MBF. MFR was comparable between the diet (2.78 +/- 0.80) and medication therapy groups (2.76 +/- 0.77) and was inversely correlated with average hemoglobin A1c for 5 years (r = -0.55, p < 0.01) and fasting plasma glucose concentration (r = -0.57, p < 0.01) but not age or lipid fractions. CONCLUSIONS: Glycemic control and gender, rather than mode of therapy, is related to MFR in NIDDM.

This article has been cited by other articles:

				R. Rubinshtein, E. H. Yang, C. S. Rihal, A. Prasad, R. J. Lennon, P. J. Best, L. O. Lerman, and A. Lerman Coronary microcirculatory vasodilator function in relation to risk factors among patients without obstructive coronary disease and low to intermediate Framingham score Eur. Heart J., November 5, 2009; (2009) ehp459v1. [Abstract] [Full Text] [PDF]

				L Cortigiani, F Rigo, R Sicari, S Gherardi, F Bovenzi, and E Picano Prognostic correlates of combined coronary flow reserve assessment on left anterior descending and right coronary artery in patients with negative stress echocardiography by wall motion criteria Heart, September 1, 2009; 95(17): 1423 - 1428. [Abstract] [Full Text] [PDF]

				A. Soylu, K. Ozdemir, M. A. Duzenli, M. Yazici, and M. Tokac Impact on Diabetes Mellitus on the Epicardial Coronary Flow Velocity Assessed by the Thrombolysis in Myocardial Infarction Frame Count Angiology, August 1, 2009; 60(4): 431 - 440. [Abstract] [PDF]

				B. I. Levy, E. L. Schiffrin, J.-J. Mourad, D. Agostini, E. Vicaut, M. E. Safar, and H. A.J. Struijker-Boudier Impaired Tissue Perfusion: A Pathology Common to Hypertension, Obesity, and Diabetes Mellitus Circulation, August 26, 2008; 118(9): 968 - 976. [Full Text] [PDF]

				K. Turkmen, H. Oflaz, B. Uslu, A. O. Cimen, A. Elitok, E. Kasikcioglu, S. Alisir, F. Tufan, S. Namli, M. Uysal, et al. Coronary Flow Velocity Reserve and Carotid Intima Media Thickness in Patients with Autosomal Dominant Polycystic Kidney Disease: From Impaired Tubules to Impaired Carotid and Coronary Arteries Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 986 - 991. [Abstract] [Full Text] [PDF]

				L. Wang, T. Y. Wong, A. R. Sharrett, R. Klein, A. R. Folsom, and M. Jerosch-Herold Relationship Between Retinal Arteriolar Narrowing and Myocardial Perfusion: Multi-Ethnic Study of Atherosclerosis Hypertension, January 1, 2008; 51(1): 119 - 126. [Abstract] [Full Text] [PDF]

				L. Cortigiani, F. Rigo, S. Gherardi, R. Sicari, M. Galderisi, F. Bovenzi, and E. Picano Additional Prognostic Value of Coronary Flow Reserve in Diabetic and Nondiabetic Patients With Negative Dipyridamole Stress Echocardiography by Wall Motion Criteria J. Am. Coll. Cardiol., October 2, 2007; 50(14): 1354 - 1361. [Abstract] [Full Text] [PDF]

				H. V. Joffe, R. Y. Kwong, M. D. Gerhard-Herman, C. Rice, K. Feldman, and G. K. Adler Beneficial Effects of Eplerenone Versus Hydrochlorothiazide on Coronary Circulatory Function in Patients with Diabetes Mellitus J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2552 - 2558. [Abstract] [Full Text] [PDF]

				Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. V. d. Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur. Heart J. Suppl., June 1, 2007; 9(suppl_C): C3 - C74. [Full Text] [PDF]

				P. G. Camici and F. Crea Coronary Microvascular Dysfunction N. Engl. J. Med., February 22, 2007; 356(8): 830 - 840. [Full Text] [PDF]

				M. M. Madsen, H. M. Sondergaard, M. Bottcher, N. H. Buus, O. Schmitz, H. E. Botker, and T. T. Nielsen Impact of Type 2 Diabetes on Nitric Oxide and Adrenergic Modulation of Myocardial Perfusion Diabetes, February 1, 2007; 56(2): 468 - 475. [Abstract] [Full Text] [PDF]

				Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur. Heart J., January 1, 2007; 28(1): 88 - 136. [Full Text] [PDF]

				Y. O'Malley, B. D. Fink, N. C. Ross, T. E. Prisinzano, and W. I. Sivitz Reactive Oxygen and Targeted Antioxidant Administration in Endothelial Cell Mitochondria J. Biol. Chem., December 29, 2006; 281(52): 39766 - 39775. [Abstract] [Full Text] [PDF]

				M. Galderisi Diastolic Dysfunction and Diabetic Cardiomyopathy: Evaluation by Doppler Echocardiography J. Am. Coll. Cardiol., October 17, 2006; 48(8): 1548 - 1551. [Abstract] [Full Text] [PDF]

				S Moir, L Hanekom, Z-Y Fang, B Haluska, C Wong, M Burgess, and T H Marwick Relationship between myocardial perfusion and dysfunction in diabetic cardiomyopathy: a study of quantitative contrast echocardiography and strain rate imaging Heart, October 1, 2006; 92(10): 1414 - 1419. [Abstract] [Full Text] [PDF]

				L. Wang, M. Jerosch-Herold, D. R. Jacobs Jr, E. Shahar, R. Detrano, A. R. Folsom, and for the MESA Study Investigators Coronary Artery Calcification and Myocardial Perfusion in Asymptomatic Adults: The MESA (Multi-Ethnic Study of Atherosclerosis) J. Am. Coll. Cardiol., September 5, 2006; 48(5): 1018 - 1026. [Abstract] [Full Text] [PDF]

				L. Wang, M. Jerosch-Herold, D. R. Jacobs Jr, E. Shahar, and A. R. Folsom Coronary Risk Factors and Myocardial Perfusion in Asymptomatic Adults: The Multi-Ethnic Study of Atherosclerosis (MESA) J. Am. Coll. Cardiol., February 7, 2006; 47(3): 565 - 572. [Abstract] [Full Text] [PDF]

				R. Lautamaki, K.E. J. Airaksinen, M. Seppanen, J. Toikka, R. Harkonen, M. Luotolahti, R. Borra, J. Sundell, J. Knuuti, and P. Nuutila Insulin Improves Myocardial Blood Flow in Patients With Type 2 Diabetes and Coronary Artery Disease Diabetes, February 1, 2006; 55(2): 511 - 516. [Abstract] [Full Text] [PDF]

				T Kawata, M Daimon, R Hasegawa, K Teramoto, T Toyoda, T Sekine, K Yamamoto, D Uchida, T Himi, K Yoshida, et al. Serum asymmetric dimethylarginine as a marker of coronary microcirculation in patients with non-insulin dependent diabetes mellitus: correlation with coronary flow reserve Heart, December 1, 2005; 91(12): 1607 - 1608. [Full Text] [PDF]

				J.-P. Collet and G. Montalescot The acute reperfusion management of STEMI in patients with impaired glucose tolerance and type 2 diabetes Diabetes and Vascular Disease Research, October 1, 2005; 2(3): 136 - 143. [Abstract] [PDF]

				H Yoshitani, M Takeuchi, K Sakamoto, T Akasaka, K Yoshida, and J Yoshikawa Effect of one or more co-morbid conditions on diagnostic accuracy of coronary flow velocity reserve for detecting significant left anterior descending coronary stenosis Heart, October 1, 2005; 91(10): 1294 - 1298. [Abstract] [Full Text] [PDF]

				P. A. Kaufmann and P. G. Camici Myocardial Blood Flow Measurement by PET: Technical Aspects and Clinical Applications J. Nucl. Med., January 1, 2005; 46(1): 75 - 88. [Full Text] [PDF]

				M. N. Zairis, A. G. Lyras, S. S. Makrygiannis, P. K. Psarogianni, E. N. Adamopoulou, S. M. Handanis, A. Papantonakos, S. K. Argyrakis, A. A. Prekates, and S. G. Foussas Type 2 Diabetes and Intravenous Thrombolysis Outcome in the Setting of ST Elevation Myocardial Infarction Diabetes Care, April 1, 2004; 27(4): 967 - 971. [Abstract] [Full Text] [PDF]

				M. F. Di Carli, J. Janisse, G. Grunberger, and J. Ager Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes J. Am. Coll. Cardiol., April 16, 2003; 41(8): 1387 - 1393. [Abstract] [Full Text] [PDF]

				A. Kjaer, C. Meyer, F. S. Nielsen, H.-H. Parving, and B. Hesse Dipyridamole, Cold Pressor Test, and Demonstration of Endothelial Dysfunction: A PET Study of Myocardial Perfusion in Diabetes J. Nucl. Med., January 1, 2003; 44(1): 19 - 23. [Abstract] [Full Text] [PDF]

				L. Ryden and K. Malmberg Who are the enemies? Diabetes mellitus -- a major risk factor for ischaemic myocardial injury: new directions in the management of acute coronary syndromes in the diabetic patient Eur. Heart J. Suppl., November 1, 2002; 4(suppl_G): G21 - G25. [Abstract] [PDF]

				J. D. Tune, C. Yeh, S. Setty, and H. F. Downey ATP-Dependent K+ Channels Contribute to Local Metabolic Coronary Vasodilation in Experimental Diabetes Diabetes, April 1, 2002; 51(4): 1201 - 1207. [Abstract] [Full Text] [PDF]

				Z. T. Bloomgarden The American Diabetes Association's 48th Annual Advanced Postgraduate Course Diabetes Care, August 1, 2001; 24(8): 1489 - 1495. [Full Text] [PDF]

				M Fujiwara, T Tamura, K Yoshida, K Nakagawa, M Nakao, M Yamanouchi, N Shikama, T Himi, and Y Masuda Coronary flow reserve in angiographically normal coronary arteries with one-vessel coronary artery disease without traditional risk factors Eur. Heart J., March 2, 2001; 22(6): 479 - 487. [Abstract] [PDF]

				T. Hammoud, J.-F. Tanguay, and M. G. Bourassa Management of coronary artery disease: therapeutic options in patients with diabetes J. Am. Coll. Cardiol., August 1, 2000; 36(2): 355 - 365. [Abstract] [Full Text] [PDF]

				D. L. Bhatt, S. P. Marso, A. M. Lincoff, K. E. Wolski, S. G. Ellis, and E. J. Topol Abciximab reduces mortality in diabetics following percutaneous coronary intervention J. Am. Coll. Cardiol., March 15, 2000; 35(4): 922 - 928. [Abstract] [Full Text] [PDF]

				K.-H. Mak and E. J. Topol Emerging concepts in the management of acute myocardial infarction in patients with diabetes mellitus J. Am. Coll. Cardiol., March 1, 2000; 35(3): 563 - 568. [Abstract] [Full Text] [PDF]

				M. F. Di Carli, D. Bianco-Batlles, M. E. Landa, A. Kazmers, H. Groehn, O. Muzik, and G. Grunberger Effects of Autonomic Neuropathy on Coronary Blood Flow in Patients With Diabetes Mellitus Circulation, August 24, 1999; 100(8): 813 - 819. [Abstract] [Full Text] [PDF]

				I. Yokoyama, S.-i. Momomura, T. Ohtake, K. Yonekura, W. Yang, N. Kobayakawa, T. Aoyagi, S. Sugiura, N. Yamada, K. Ohtomo, et al. Improvement of Impaired Myocardial Vasodilatation Due to Diffuse Coronary Atherosclerosis in Hypercholesterolemics After Lipid-Lowering Therapy Circulation, July 13, 1999; 100(2): 117 - 122. [Abstract] [Full Text] [PDF]

				I. Yokoyama, T. Ohtake, S.-i. Momomura, K. Yonekura, N. Kobayakawa, T. Aoyagi, S. Sugiura, Y. Sasaki, and M. Omata Altered Myocardial Vasodilatation in Patients With Hypertriglyceridemia in Anatomically Normal Coronary Arteries Arterioscler Thromb Vasc Biol, February 1, 1998; 18(2): 294 - 299. [Abstract] [Full Text] [PDF]